Page 83 - AN-2-2

Advanced Neurology Role of immunosuppressants in autism

10: 267–275. Fibroadipogenic progenitors mediate the ability of HDAC
inhibitors to promote regeneration in dystrophic muscles of
https://doi.org/10.1016/j.autrev.2010.09.015
young, but not old Mdx mice. EMBO Mol Med, 5: 626–639.
123. Ricote M, Glass CK, 2007, PPARs and molecular
mechanisms of transrepression. Biochim Biophys Acta, https://doi.org/10.1002/emmm.201202096
1771: 926–935. 134. Maltzman JS, Koretzky GA, 2003, Azathioprine: Old drug,
new actions. J Clin Investig, 111: 1122–1124.
https://doi.org/10.1016/j.bbalip.2007.02.013
https://doi.org/10.1172/jci200318384
124. Bussey H, 1975, Familial Polyposis Coli. Family Studies,
Histopathology, Differential Diagnosis, and Results of 135. Elion GB, Hitchings GH, 1975, Azathioprine, in
Treatment. United States: The John Hopkins University Antineoplastic and Immunosuppressive Agents. Berlin:
Press. p 47–49. Springer. p 404–425.
https://doi.org/10.7326/0003-4819-83-6-924_1 https://doi.org/10.1007/978-3-642-65806-8_19
125. Nieuwenhuis MH, Vasen HF, 2007, Correlations 136. Aarbakke J, Janka-Schaub G, Elion GB, 1997, Thiopurine
between mutation site in APC and phenotype of familial biology and pharmacology. Trends Pharmacol Sci, 18: 3–7.
adenomatous polyposis (FAP): A review of the literature. https://doi.org/10.1016/s0165-6147(96)01007-3
Crit Rev Oncol Hematol, 61: 153–161.
137. Elion GB, 1993, The george hitchings and gertrude elion
https://doi.org/10.1016/j.critrevonc.2006.07.004
lecture. The pharmacology of azathioprine. Ann N Y Acad
126. Nishisho I, Nakamura Y, Miyoshi Y, et al., 1991, Mutations Sci, 685: 400–407.
of chromosome 5q21 genes in FAP and colorectal cancer https://doi.org/10.1111/j.1749-6632.1993.tb35896.x
patients. Science, 253: 665–669.
138. Huang HY, Chang HF, Tsai MJ, et al., 2016,
https://doi.org/10.1126/science.1651563
6-Mercaptopurine attenuates tumor necrosis factor-α
127. Kinzler KW, Nilbert MC, Su LK, et al., 1991, Identification production in microglia through Nur77-mediated
of FAP locus genes from chromosome 5q21. Science, transrepression and PI3K/Akt/mTOR signaling-mediated
253: 661–665. translational regulation. J Neuroinflamm, 13: 78.
https://doi.org/10.1126/science.1651562 https://doi.org/10.1186/s12974-016-0543-5
128. Goss KH, Groden J, 2000, Biology of the adenomatous 139. Hooper KM, Casanova V, Kemp S, et al., 2019, The
polyposis coli tumor suppressor. J Clin Oncol, 18: 1967–1979. inflammatory bowel disease drug azathioprine induces
autophagy via mTORC1 and the unfolded protein response
https://doi.org/10.1200/jco.2000.18.9.1967
sensor PERK. Inflamm Bowel Dis, 25: 1481–1496.
129. Sieber OM, Tomlinson IP, Lamlum H, 2000, The
adenomatous polyposis coli (APC) tumour suppressor-- https://doi.org/10.1093/ibd/izz039
genetics, function and disease. Mol Med Today, 6: 462–469. 140. Green MR, Kennell AS, Larche MJ, et al., 2005, Natural
killer cell activity in families of patients with systemic
https://doi.org/10.1016/s1357-4310(00)01828-1
lupus erythematosus: Demonstration of a killing defect in
130. Maffini V, Fornaroli F, Vincenzi F, et al., 2008, Autism and patients. Clin Exp Immunol, 141: 165–173.
gastrointestinal disorders: A close relationship? Dig Liver
Dis, 40: A93. https://doi.org/10.1111/j.1365-2249.2005.02822.x
141. Ehninger D, Silva AJ, 2011, Rapamycin for treating
https://doi.org/10.1016/j.dld.2008.07.265
Tuberous sclerosis and Autism spectrum disorders. Trends
131. Zhou XL, Giacobini M, Anderlid BM, et al., 2007, Mol Med, 17: 78–87.
Association of adenomatous polyposis coli (APC) gene https://doi.org/10.1016/j.molmed.2010.10.002
polymorphisms with autism spectrum disorder (ASD).
Am J Med Genet B Neuropsychiatr Genet, 144B: 351–354. 142. Pithadia AB, Jain S, 2011, Treatment of inflammatory
bowel disease (IBD). Pharmacol Rep, 63: 629–642.
https://doi.org/10.1002/ajmg.b.30415
https://doi.org/10.1016/s1734-1140(11)70575-8
132. Reggio A, Spada F, Rosina M, et al., 2019, The
immunosuppressant drug azathioprine restrains 143. McWilliam M, Khan U, 2020, Azathioprine and the
adipogenesis of muscle Fibro/Adipogenic Progenitors neurologist. Pract Neurol, 20: 69–74.
from dystrophic mice by affecting AKT signaling. Sci Rep, 144. Viana SD, Reis F, Alves R, 2018, Therapeutic use of mTOR
9: 4360.
inhibitors in renal diseases: Advances, drawbacks, and
https://doi.org/10.1038/s41598-019-39538-y challenges. Oxid Med Cell Longev, 2018: 3693625.
133. Mozzetta C, Consalvi S, Saccone V, et al., 2003, https://doi.org/10.1155/2018/3693625

Volume 2 Issue 2 (2023) 23 https://doi.org/10.36922/an.391